Clinical trial
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory…
NCT00099489 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00099489 |
|---|---|
| Title | Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Safety and Efficacy of AVONEX When Used in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
| Intervention type | Drug |
| Interventions | Interferon Beta-1a |
| Enrollment | 67 |
| Start date | Feb 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Dec 16, 2004 |
| Last update posted | Mar 5, 2010 |
| Countries | Australia, Canada, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: